Scientific papers

Please use the menu on the right to browse publications by year, cancer type or author, or enter a search term in the box below.

Displaying 1 - 10 of 24 papers
Click here to reset all search parameters [1]

Screening status, tumour subtype, and breast cancer survival: a national population-based analysis [2]

O’Brien KM, Mooney T, Fitzpatrick P, Sharp L..

Breast Cancer Res Treat. 2018 Jul 13. [Epub ahead of print].
Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group [3]

Derks MGM, Bastiaannet E, Kiderlen M, Hilling DE, Boelens PG, Walsh PM, van Eycken E, Siesling S, Broggio J, Wyld L, Trojanowski M, Kolacinska A, Chalubinska-Fendler J, Gonçalves AF, Nowikiewicz T, Zegarski W, Audisio RA, Liefers GJ, Portielje JEA, et al..

Br J Cancer. 2018;119(1):121-129.
Health-related quality of life in a predictive model for mortality in older breast cancer survivors [4]

DuMontier C, Clough-Gorr KM, Silliman RA, Stuck AE, Moser A.

J Am Geriatr Soc. 2018;66(6):1115-1122.
Mortality reductions due to mammography screening: Contemporary population-based data [5]

Hanley JA, Hannigan A, O'Brien KM.

PLOS ONE. 2017;12(12):e0188947.
Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I-III breast cancer? [6]

Cahir C, Barron TI, Sharp L, Bennett K..

Cancer Causes Control. 2017;28(3):215-225.
Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors [7]

Sharp L, Timmons A.

Support Care Cancer. 2016;24(2):699-709.
Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study [8]

de Camargo Cancela M, Comber H, Sharp L.

Cancer Epidemiol. 2015;39(5):778-82.
Interval cancer rates in the Irish national breast screening programme [9]

O’Brien, K. M., Dwane, F., Kelleher, T., Sharp, L., & Comber, H..

J Med Screen. 2015;22(3):136-43.
De-novo post-diagnosis aspirin use and mortality in women with stage I-III breast cancer [10]

Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L.

Cancer Epidemiol Biomarkers Prev. 2015;24(6):898-904.
Treatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and Ireland [11]

Kiderlen M, Walsh PM, Bastiaannet E, Kelly MB, Audisio RA, Boelens PG, Brown C, Dekkers OM, de Craen JM, van de Velde CJH, Liefers GJ..

PLOS ONE. 2015;10(2):e0118074.

Pages

[14]

[15]